Track topics on Twitter Track topics that are important to you
With over $1.4 billion under management, we have been actively engaged in the business of venture capital since 1988, investing in over 200 companies to date. Our network of approximately 50 active portfolio companies, investment resources, professional contacts and service providers makes us one of the most active firms in the market.
TL Ventures invests in companies led by outstanding management teams capable of building category-defining businesses in the software, information technology infrastructure and services, communications and biotechnology industries. Our team of investment professionals offers an extensive network of nationwide contacts and resources. We also assist early stage companies with business and product strategy, recruiting, technology partnerships, business and channel development and financing.
At TL Ventures, we are committed to working in partnership with our companies as they grow from concepts to successful organizations. The results achieved by our portfolio companies, showcases the success of our approach.
With hands-on experience in start-ups, engineering, operations, marketing and finance, our team of capable investment professionals is uniquely qualified to support you in the boardroom and day-to-day management. We understand entrepreneurs because many of our investment professionals have themselves started companies and subsequently taken them public or guided them through successful mergers or acquisitions.
435 Devon Park Drive700 Building
United States of America
Immuno-oncology start-up Palleon Pharmaceuticals brought in $47.6mm through its Series A round from SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, and AbbVie Ventures.
The round was led by New Enterprise Associates and joined by Sofinnova Ventures and Vida Ventures, as well as existing investors OrbiMed, SV Health Investors, Osage University Partners, and Mission Ba...
Seed funders Polaris Partners and Avalon Ventures were joined in the Series A syndicate by Versant Ventures, AbbVie Ventures, and Pfizer R&D Innovate.
HealthiPASS, a Chicago-based healthcare payments company, today announced it has raised a $7.2 million in Series A funding round, led by FCA Venture Partners. The round also included participation ...
Presented in partnership with Madrona Venture Group, Notion Capital and Vertex Ventures Israel. SAN FRANCISCO, Oct. 10, 2017 /PRNewswire/ -- Microsoft Ventures, in collaboration with Madrona Ventu...
Collective Medical, a Utah-based network for care collaboration has raised $47 million in Series A funding led by Kleiner Perkins with participation from Bessemer Venture Partners, Maverick Ventures, ...
The Series A was led by GV, with participation from AtlasVenture, Takeda Ventures, Vertex Ventures HC, Amgen Ventures, Alexandria Venture Investments, and ShangPharma Group.
The investments indicate mounting cross-industry support for Contrast's unique software security approach. AXA Strategic Ventures is the venture capital fund backed by AXA, the leading Read more.....
B4 Brands: Avant EX Instant Hand Sanitizer
B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free
B4 Brands: Avant Original Instant Hand Sanitizer
B4 Brands: Aterra Antibacterial Hand Soap
B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer
The Instabul Convention is a normative tool for the prevention of women's violence in Europe. Rome 5 Local Healthcare Authority has implemented a synergistic intervention model in joint ventures with ...
Research on renewable biofuels produced by microorganisms has enjoyed considerable advances in academic and industrial settings. As the renewable ethanol market approaches maturity, the demand is risi...
It is broadly acknowledged that natural resources conservation strategies affect the livelihoods of local communities. Moreover, evidence suggests that these livelihood impacts, in turn, can influence...
Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...
GE Ventures is committed to identifying, scaling and accelerating ideas that will make the world work better. Focused on the areas of software, advanced manufacturing, energy and ...
Founded in 2007 by a group of concerned parents, Extraordinary Ventures (EV) is a 501(c)(3) enterprise that creates and operates a portfolio of self-sustaining small, local busine...
Founded in 2003, Jina Ventures is a New York-based private equity and M&A advisory firm. Over the past 6 years, Jina Ventures has grown into a full service private equity practice, with both principal...
Rizk Ventures is a privately-held investment firm based in New York, founded by Thomas A. Rizk and Linda Rizk. Rizk Ventures focuses on investment activities in the areas of Ventu...
Residex Ventures provides capital and expertise to accelerate market traction for technology companies. The focus is private equity from start-up to pre-listing phases of innovative European and North...
We have published hundreds of TL Ventures news stories on BioPortfolio along with dozens of TL Ventures Clinical Trials and PubMed Articles about TL Ventures for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TL Ventures Companies in our database. You can also find out about relevant TL Ventures Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...